封面
市场调查报告书
商品编码
1166087

脑室引流的全球市场:现状分析与预测(2022年~2028年)

External Ventricular Drain Market: Current Analysis and Forecast (2022-2028)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 154 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球脑室引流的市场规模,在预测期间内预计以约7%的年复合成长率成长。各种神经疾病的盛行率增加,全球交通事故数量的增加创伤性脑损伤增加,迅速的技术进步,研究开发活动的高涨,促进市场成长。

本报告提供全球脑室引流市场的相关调查,市场洞察,市场趋势,竞争模式,企业概要等全面性资讯。

目录

第1章 市场简介

  • 市场定义
  • 主要目的
  • 相关利益者
  • 限制

第2章 调查方法或假设

  • 脑室引流市场调查流程
  • 脑室引流市场调查手法
  • 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对脑室引流市场的影响

第6章 脑室引流市场收益(2022年~2028年)

第7章 市场洞察:各用途

  • 创伤性脑损伤
  • 颅内出血
  • 水脑症
  • 其他

第8章 市场洞察:各终端用户

  • 医院
  • 门诊病人手术中心
  • 其他

第9章 市场洞察:各地区

  • 北美
    • 美国
    • 加拿大
    • 其他北美
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区

第10章 脑室引流市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第11章 脑室引流的市场机会

第12章 脑室引流的市场趋势

第13章 需求面和供给方面的分析

  • 需求面分析
  • 供给面

第14章 价值链分析

第15章 竞争模式

  • 竞争情形
    • 波特的五力分析

第16章 企业概要

  • Medtronic Plc
  • Spiegelberg Gmbh & Co. Kg
  • Moller Medical Gmbh
  • Braun Melsungen Ag
  • Integra Life Sciences Corporation
  • Pfizer Inc.
  • Cadila Pharmaceuticals
  • Sophysa
  • Fuji Systems
  • Geistlich Pharma Inc.

第17章 免责声明

简介目录
Product Code: UMHE211280

Global External Ventricular Drain Market is expected to grow at a significant rate of around 7% during the forecast period. The global external ventricular drain market is anticipated to witness an uptick owing to the growing prevalence of various neurological disorders and the rise in traumatic brain injuries due to an increase in the number of road accidents across the world. For instance, According to the World Health Organization, approximately 1.3 million people die every year as a result of road traffic crashes. Between 20 and 50 million more people suffer non-fatal injuries, with many incurring a disability as a result of their injury. Also, as per the United Nations data, in February 2021, nearly 1 in 6 of the world's population, suffer from neurological disorders, such as Alzheimer's and Parkinson's disease, strokes, etc. Furthermore, rapid technological advancement, rising research and development activities and an increasing need for minimally invasive or non-invasive neurosurgeries to reduce trauma and improve patient outcomes are also some of the factors contributing to the growth of the external ventricular drain market across the globe.

Medtronic Plc, Spiegelberg Gmbh & Co. Kg, Moller Medical Gmbh, Braun Melsungen Ag, Integra Life Sciences Corporation, Pfizer Inc., Cadila Pharmaceuticals, Sophysa, Fuji Systems, Geistlich Pharma Inc are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new and innovative products.

Insights Presented in the Report

"Amongst application, traumatic brain injury category to witness higher CAGR during the forecast period"

Based on the application, the external ventricular drain market is segmented into traumatic brain injury, intracranial haemorrhage, hydrocephalus, and others. The traumatic brain injury segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to an increase in the number of road accidents leading to rise in the prevalence of traumatic brain injuries. However, the hydrocephalus segment is also expected to grow considerably during the forecast period as it affects a large number of people globally.

"Amongst end-user, the hospitals segment to hold a significant share in the market in 2020"

Based on end-user, the market is fragmented into hospitals, ambulatory surgical centers and others. The hospitals segment is expected to grab a considerable market share in 2020 and is expected to grow with a lucrative CAGR during the forecast period. This can be due to an increased preference for patients to get treatment in hospitals owing to the presence of skilled healthcare professionals, availability of technologically advanced equipment, and a well-established infrastructure.

"North America to hold a significant share in the market"

North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, high incidences of traumatic brain injuries and a growing prevalence of neurovascular disorders in the region. For instance, as per the CDC, stroke is the fifth leading cause of death and over 140,000 people are killed due to cerebrovascular stroke each year in the U.S. Furthermore, rapid technological advancements and the presence of major medical equipment companies are also contributing towards the growth of the market for the external ventricular drain in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global external ventricular drain market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the External Ventricular Drain Market
  • 2.2. Research Methodology of the External Ventricular Drain Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE EXTERNAL VENTRICULAR DRAIN MARKET

6 EXTERNAL VENTRICULAR DRAIN MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY APPLICATION

  • 7.1. Traumatic Brain Injury
  • 7.2. Intracranial Haemorrhage
  • 7.3. Hydrocephalus
  • 7.4. Others

8 MARKET INSIGHTS BY END-USER

  • 8.1. Hospitals
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Others

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 EXTERNAL VENTRICULAR DRAIN MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 EXTERNAL VENTRICULAR DRAIN MARKET OPPORTUNITIES

12 EXTERNAL VENTRICULAR DRAIN MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Medtronic Plc
  • 16.2. Spiegelberg Gmbh & Co. Kg
  • 16.3. Moller Medical Gmbh
  • 16.4. Braun Melsungen Ag
  • 16.5. Integra Life Sciences Corporation
  • 16.6. Pfizer Inc.
  • 16.7. Cadila Pharmaceuticals
  • 16.8. Sophysa
  • 16.9. Fuji Systems
  • 16.10. Geistlich Pharma Inc.

17 DISCLAIMER